Henry Walch

2.2k total citations
44 papers, 280 citations indexed

About

Henry Walch is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Henry Walch has authored 44 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 15 papers in Cancer Research. Recurrent topics in Henry Walch's work include Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Henry Walch is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Cancer Genomics and Diagnostics (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Henry Walch collaborates with scholars based in United States, Ireland and Chile. Henry Walch's co-authors include Nikolaus Schultz, Walid K. Chatila, Rona Yaeger, Sebastián Mondaca, Jinru Shia, Subhiksha Nandakumar, Andrea Cercek, Francisco Sánchez-Vega, Laura H. Tang and Mithat Gönen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Henry Walch

40 papers receiving 280 citations

Peers

Henry Walch
Shiaowen David Hsu United States
Henry Walch
Citations per year, relative to Henry Walch Henry Walch (= 1×) peers Shiaowen David Hsu

Countries citing papers authored by Henry Walch

Since Specialization
Citations

This map shows the geographic impact of Henry Walch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Walch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Walch more than expected).

Fields of papers citing papers by Henry Walch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Walch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Walch. The network helps show where Henry Walch may publish in the future.

Co-authorship network of co-authors of Henry Walch

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Walch. A scholar is included among the top collaborators of Henry Walch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Walch. Henry Walch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Artz, Oliver, Peter Ntiamoah, Caroline Weipert, et al.. (2025). Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 32(6). 1100–1109. 1 indexed citations
2.
Cuevas-Navarro, Antonio, Emily G. Shuldiner, Walid K. Chatila, et al.. (2025). RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma. Cancer Research. 85(17). 3196–3206. 1 indexed citations
4.
Johannet, Paul, Henry Walch, Benoı̂t Rousseau, et al.. (2024). Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors. Journal of Clinical Oncology. 42(32). 3847–3857. 5 indexed citations
5.
Keane, Fergus, Joanne F. Chou, Henry Walch, et al.. (2024). Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease. JNCI Journal of the National Cancer Institute. 116(9). 1429–1438. 2 indexed citations
6.
Cercek, Andrea, Jinru Shia, Jill Weiss, et al.. (2024). Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer.. Journal of Clinical Oncology. 42(17_suppl). LBA3512–LBA3512. 35 indexed citations
7.
Keane, Fergus, Henry Walch, Joanne F. Chou, et al.. (2024). Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer. Clinical Cancer Research. 30(12). 2672–2683. 5 indexed citations
8.
Foote, Michael B., James R. White, Walid K. Chatila, et al.. (2024). Analysis of Shared Variants between Cancer Biospecimens. Clinical Cancer Research. 31(2). 376–386.
9.
Mondaca, Sebastián, Henry Walch, Nikolaus Schultz, et al.. (2024). Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort. JCO Global Oncology. 10(10). e2400090–e2400090. 1 indexed citations
10.
Gui, Chengcheng, Henry Walch, Ahmet Turan Ilıca, et al.. (2024). Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases. Journal of neurosurgery. 142(2). 1–11.
11.
Skakodub, Anna, Henry Walch, Kathryn R. Tringale, et al.. (2023). Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature Communications. 14(1). 4980–4980. 28 indexed citations
12.
Ecker, Brett L., Quisette P. Janssen, Henry Walch, et al.. (2023). Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 29(7). 1368–1374. 13 indexed citations
13.
Foote, Michael B., Henry Walch, Yelena Kemel, et al.. (2023). The Impact of Germline Alterations in Appendiceal Adenocarcinoma. Clinical Cancer Research. 29(14). 2631–2637. 2 indexed citations
14.
Capanu, Marinela, Fergus Keane, Danny N. Khalil, et al.. (2023). P-266 Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI). Annals of Oncology. 34. S109–S109. 1 indexed citations
15.
Bhatia, Ankush, Anne S. Reiner, Subhiksha Nandakumar, et al.. (2023). Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma. Clinical Cancer Research. 30(1). 106–115. 13 indexed citations
16.
Gaëta, Bruno, Henry Walch, Lukáš Kratochvíl, et al.. (2023). The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 117(2). e101–e102. 2 indexed citations
17.
Özer, Muhammet, Nicolas Lecomte, Juan M. Schvartzman, et al.. (2022). Concurrent GermlineBRCA1/2and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options. JCO Precision Oncology. 6(6). e2100560–e2100560. 3 indexed citations
18.
Narayan, Raja R., Victoria G. Aveson, Joanne F. Chou, et al.. (2022). Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years. Journal of Surgical Oncology. 125(5). 880–888. 5 indexed citations
19.
Narayan, Raja R., Jashodeep Datta, Debra A. Goldman, et al.. (2022). Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy. Annals of Surgical Oncology. 29(12). 7579–7588. 6 indexed citations
20.
Mondaca, Sebastián, Henry Walch, Subhiksha Nandakumar, et al.. (2020). Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer. Gastroenterology. 159(5). 1975–1978.e4. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026